HEADER IMMUNE SYSTEM 11-MAY-04 1T83 TITLE CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX TITLE 2 WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC) CAVEAT 1T83 NAG D 1 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: IGG1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: FC; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: LOW AFFINITY IMMUNOGLOBULIN GAMMA FC REGION RECEPTOR III-B; COMPND 7 CHAIN: C; COMPND 8 FRAGMENT: FC GAMMA RECEPTOR TYPE III; COMPND 9 SYNONYM: IGG FC RECEPTOR III-1, FC-GAMMA RIII-BETA, FC-GAMMA RIIIB, COMPND 10 FCRIIIB, FC-GAMMA RIII, FCRIII, CD16-B, FCR-10; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 7 ORGANISM_COMMON: HUMAN; SOURCE 8 ORGANISM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 11 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 12 EXPRESSION_SYSTEM_VECTOR_TYPE: PET; SOURCE 13 EXPRESSION_SYSTEM_VECTOR: 28B KEYWDS FC GAMMA RECEPTOR, IGG1, CD16, FCGRIII, IMMUNOGLOBULIN, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR S.RADAEV,S.MOTYKA,W.-H.FRIDMAN,C.SAUTES-FRIDMAN,P.D.SUN REVDAT 6 23-AUG-23 1T83 1 REMARK HETSYN REVDAT 5 29-JUL-20 1T83 1 CAVEAT COMPND REMARK HETNAM REVDAT 5 2 1 LINK SITE ATOM REVDAT 4 13-JUL-11 1T83 1 VERSN REVDAT 3 24-FEB-09 1T83 1 VERSN REVDAT 2 24-JUL-07 1T83 1 SPRSDE REVDAT 1 28-SEP-04 1T83 0 SPRSDE 24-JUL-07 1T83 1IIS JRNL AUTH S.RADAEV,S.MOTYKA,W.-H.FRIDMAN,C.SAUTES-FRIDMAN,P.D.SUN JRNL TITL THE STRUCTURE OF A HUMAN TYPE III FCGAMMA RECEPTOR IN JRNL TITL 2 COMPLEX WITH FC JRNL REF J.BIOL.CHEM. V. 276 16469 2001 JRNL REFN ISSN 0021-9258 JRNL PMID 11297532 JRNL DOI 10.1074/JBC.M100350200 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 17780 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 872 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4719 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 198 REMARK 3 SOLVENT ATOMS : 120 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 82.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -41.96300 REMARK 3 B22 (A**2) : 13.38800 REMARK 3 B33 (A**2) : 28.57500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.670 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : HGBR2.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : HGBR2.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1T83 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-MAY-04. REMARK 100 THE DEPOSITION ID IS D_1000022429. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.03320 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : CUSTOM-MADE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19063 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06100 REMARK 200 FOR THE DATA SET : 21.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.46000 REMARK 200 FOR SHELL : 3.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1FNL AND 1FC1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4000, HEPES, HGBR2, PH 6.0, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.92300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.53450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.19250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 61.53450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.92300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 51.19250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 224 REMARK 465 THR A 225 REMARK 465 CYS A 226 REMARK 465 PRO A 227 REMARK 465 PRO A 228 REMARK 465 CYS A 229 REMARK 465 PRO A 230 REMARK 465 ALA A 231 REMARK 465 PRO A 232 REMARK 465 GLU A 233 REMARK 465 LEU A 234 REMARK 465 PRO A 445 REMARK 465 GLY A 446 REMARK 465 LYS A 447 REMARK 465 HIS B 224 REMARK 465 THR B 225 REMARK 465 CYS B 226 REMARK 465 PRO B 227 REMARK 465 PRO B 228 REMARK 465 CYS B 229 REMARK 465 PRO B 230 REMARK 465 ALA B 231 REMARK 465 SER B 444 REMARK 465 PRO B 445 REMARK 465 GLY B 446 REMARK 465 LYS B 447 REMARK 465 ARG C 1 REMARK 465 THR C 2 REMARK 465 GLU C 3 REMARK 465 ASP C 4 REMARK 465 ILE C 172 REMARK 465 THR C 173 REMARK 465 GLN C 174 REMARK 465 GLY C 175 REMARK 465 LEU C 176 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 290 CB REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLN A 295 O2 FUL D 8 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 272 CD GLU A 272 OE2 0.078 REMARK 500 GLU B 272 CD GLU B 272 OE2 0.080 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 265 49.37 80.55 REMARK 500 PRO A 271 69.57 -68.51 REMARK 500 HIS A 285 18.81 -142.00 REMARK 500 ALA A 287 152.29 -7.45 REMARK 500 ARG A 292 92.39 -160.60 REMARK 500 GLU A 294 -161.83 -170.88 REMARK 500 GLN A 295 -137.96 62.77 REMARK 500 TYR A 296 46.34 -97.75 REMARK 500 SER A 298 30.02 -92.08 REMARK 500 HIS A 310 -75.82 -39.06 REMARK 500 ASP A 312 -75.07 -49.99 REMARK 500 LYS A 320 126.21 -23.33 REMARK 500 ALA A 327 -17.27 -49.83 REMARK 500 PRO A 331 147.69 -35.09 REMARK 500 ARG A 355 -60.07 -28.18 REMARK 500 SER A 400 -75.21 -31.60 REMARK 500 ASP A 401 -27.70 -32.39 REMARK 500 SER A 403 -157.48 -102.58 REMARK 500 ARG A 416 -73.97 -43.44 REMARK 500 ASN A 421 -171.61 -59.67 REMARK 500 LEU B 235 -6.67 -52.83 REMARK 500 SER B 267 -176.15 -63.27 REMARK 500 ASN B 286 38.21 -96.25 REMARK 500 LYS B 290 130.85 -178.34 REMARK 500 GLN B 295 -82.02 -53.67 REMARK 500 TYR B 296 -32.06 -34.47 REMARK 500 SER B 298 75.22 44.96 REMARK 500 ASP B 312 -32.98 -36.26 REMARK 500 LYS B 317 93.76 9.84 REMARK 500 PRO B 353 152.45 -46.55 REMARK 500 ARG B 355 -53.07 -27.03 REMARK 500 GLU B 356 3.25 -69.22 REMARK 500 PRO B 374 -173.14 -63.69 REMARK 500 SER B 383 -90.18 -96.32 REMARK 500 PRO B 387 151.28 -38.43 REMARK 500 ASN B 390 77.23 -62.52 REMARK 500 ASP B 401 23.99 -66.06 REMARK 500 ASN B 421 -175.05 -55.49 REMARK 500 SER B 424 135.35 -170.97 REMARK 500 HIS B 433 33.11 -73.84 REMARK 500 ASN B 434 32.67 164.59 REMARK 500 HIS B 435 19.13 50.75 REMARK 500 GLN C 15 -3.00 -53.43 REMARK 500 GLU C 21 47.20 -72.50 REMARK 500 LYS C 22 -21.66 -161.18 REMARK 500 PRO C 35 -80.99 -51.31 REMARK 500 GLU C 36 51.80 -90.07 REMARK 500 ASP C 37 109.12 -162.68 REMARK 500 ASN C 45 77.89 62.96 REMARK 500 GLU C 46 -53.46 76.62 REMARK 500 REMARK 500 THIS ENTRY HAS 67 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HG2 A 456 HG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 MET A 252 SD REMARK 620 2 HG2 A 456 BR1 115.2 REMARK 620 3 HG2 A 456 BR2 123.3 69.7 REMARK 620 N 1 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1IIS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FCG RECEPTOR IN COMPLEX WITH AN FC REMARK 900 FRAGMENT OF IGG1 (ORTHORHOMBIC) REMARK 900 RELATED ID: 1IIX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FCG RECEPTOR IN COMPLEX WITH AN FC REMARK 900 FRAGMENT OF IGG1 (HEXAGONAL) REMARK 900 RELATED ID: 1FNL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF A HUMAN FCGRIII REMARK 900 RELATED ID: 1F6A RELATED DB: PDB REMARK 900 STRUCTURE OF THE HUMAN IGE-FC BOUND TO ITS HIGH AFFINITY RECEPTOR REMARK 900 FC(E)RI(A) REMARK 900 RELATED ID: 1E4K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-RECEPTOR III REMARK 900 COMPLEX REMARK 900 RELATED ID: 1T89 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX REMARK 900 WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL) DBREF 1T83 A 224 447 GB 9857753 AAG00909 106 329 DBREF 1T83 B 224 447 GB 9857753 AAG00909 106 329 DBREF 1T83 C 1 176 UNP O75015 FC3B_HUMAN 19 194 SEQRES 1 A 224 HIS THR CYS PRO PRO CYS PRO ALA PRO GLU LEU LEU GLY SEQRES 2 A 224 GLY PRO SER VAL PHE LEU PHE PRO PRO LYS PRO LYS ASP SEQRES 3 A 224 THR LEU MET ILE SER ARG THR PRO GLU VAL THR CYS VAL SEQRES 4 A 224 VAL VAL ASP VAL SER HIS GLU ASP PRO GLU VAL LYS PHE SEQRES 5 A 224 ASN TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN ALA LYS SEQRES 6 A 224 THR LYS PRO ARG GLU GLU GLN TYR ASN SER THR TYR ARG SEQRES 7 A 224 VAL VAL SER VAL LEU THR VAL LEU HIS GLN ASP TRP LEU SEQRES 8 A 224 ASN GLY LYS GLU TYR LYS CYS LYS VAL SER ASN LYS ALA SEQRES 9 A 224 LEU PRO ALA PRO ILE GLU LYS THR ILE SER LYS ALA LYS SEQRES 10 A 224 GLY GLN PRO ARG GLU PRO GLN VAL TYR THR LEU PRO PRO SEQRES 11 A 224 SER ARG GLU GLU MET THR LYS ASN GLN VAL SER LEU THR SEQRES 12 A 224 CYS LEU VAL LYS GLY PHE TYR PRO SER ASP ILE ALA VAL SEQRES 13 A 224 GLU TRP GLU SER ASN GLY GLN PRO GLU ASN ASN TYR LYS SEQRES 14 A 224 THR THR PRO PRO VAL LEU ASP SER ASP GLY SER PHE PHE SEQRES 15 A 224 LEU TYR SER LYS LEU THR VAL ASP LYS SER ARG TRP GLN SEQRES 16 A 224 GLN GLY ASN VAL PHE SER CYS SER VAL MET HIS GLU ALA SEQRES 17 A 224 LEU HIS ASN HIS TYR THR GLN LYS SER LEU SER LEU SER SEQRES 18 A 224 PRO GLY LYS SEQRES 1 B 224 HIS THR CYS PRO PRO CYS PRO ALA PRO GLU LEU LEU GLY SEQRES 2 B 224 GLY PRO SER VAL PHE LEU PHE PRO PRO LYS PRO LYS ASP SEQRES 3 B 224 THR LEU MET ILE SER ARG THR PRO GLU VAL THR CYS VAL SEQRES 4 B 224 VAL VAL ASP VAL SER HIS GLU ASP PRO GLU VAL LYS PHE SEQRES 5 B 224 ASN TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN ALA LYS SEQRES 6 B 224 THR LYS PRO ARG GLU GLU GLN TYR ASN SER THR TYR ARG SEQRES 7 B 224 VAL VAL SER VAL LEU THR VAL LEU HIS GLN ASP TRP LEU SEQRES 8 B 224 ASN GLY LYS GLU TYR LYS CYS LYS VAL SER ASN LYS ALA SEQRES 9 B 224 LEU PRO ALA PRO ILE GLU LYS THR ILE SER LYS ALA LYS SEQRES 10 B 224 GLY GLN PRO ARG GLU PRO GLN VAL TYR THR LEU PRO PRO SEQRES 11 B 224 SER ARG GLU GLU MET THR LYS ASN GLN VAL SER LEU THR SEQRES 12 B 224 CYS LEU VAL LYS GLY PHE TYR PRO SER ASP ILE ALA VAL SEQRES 13 B 224 GLU TRP GLU SER ASN GLY GLN PRO GLU ASN ASN TYR LYS SEQRES 14 B 224 THR THR PRO PRO VAL LEU ASP SER ASP GLY SER PHE PHE SEQRES 15 B 224 LEU TYR SER LYS LEU THR VAL ASP LYS SER ARG TRP GLN SEQRES 16 B 224 GLN GLY ASN VAL PHE SER CYS SER VAL MET HIS GLU ALA SEQRES 17 B 224 LEU HIS ASN HIS TYR THR GLN LYS SER LEU SER LEU SER SEQRES 18 B 224 PRO GLY LYS SEQRES 1 C 176 ARG THR GLU ASP LEU PRO LYS ALA VAL VAL PHE LEU GLU SEQRES 2 C 176 PRO GLN TRP TYR SER VAL LEU GLU LYS ASP SER VAL THR SEQRES 3 C 176 LEU LYS CYS GLN GLY ALA TYR SER PRO GLU ASP ASN SER SEQRES 4 C 176 THR GLN TRP PHE HIS ASN GLU SER LEU ILE SER SER GLN SEQRES 5 C 176 ALA SER SER TYR PHE ILE ASP ALA ALA THR VAL ASN ASP SEQRES 6 C 176 SER GLY GLU TYR ARG CYS GLN THR ASN LEU SER THR LEU SEQRES 7 C 176 SER ASP PRO VAL GLN LEU GLU VAL HIS ILE GLY TRP LEU SEQRES 8 C 176 LEU LEU GLN ALA PRO ARG TRP VAL PHE LYS GLU GLU ASP SEQRES 9 C 176 PRO ILE HIS LEU ARG CYS HIS SER TRP LYS ASN THR ALA SEQRES 10 C 176 LEU HIS LYS VAL THR TYR LEU GLN ASN GLY LYS ASP ARG SEQRES 11 C 176 LYS TYR PHE HIS HIS ASN SER ASP PHE HIS ILE PRO LYS SEQRES 12 C 176 ALA THR LEU LYS ASP SER GLY SER TYR PHE CYS ARG GLY SEQRES 13 C 176 LEU VAL GLY SER LYS ASN VAL SER SER GLU THR VAL ASN SEQRES 14 C 176 ILE THR ILE THR GLN GLY LEU MODRES 1T83 ASN A 297 ASN GLYCOSYLATION SITE MODRES 1T83 ASN B 297 ASN GLYCOSYLATION SITE HET NAG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HET MAN D 4 11 HET NDG D 5 14 HET GAL D 6 11 HET BMA D 7 11 HET FUL D 8 10 HET NAG E 1 14 HET NDG E 2 14 HET BMA E 3 11 HET MAN E 4 11 HET NAG E 5 14 HET MAN E 6 11 HET NAG E 7 14 HET FUL E 8 10 HET HG2 A 456 3 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM FUL BETA-L-FUCOPYRANOSE HETNAM HG2 DIBROMOMERCURY HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN NDG N-ACETYL-ALPHA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NDG ALPHA-D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2- HETSYN 3 NDG ACETAMIDO-2-DEOXY-GLUCOSE; 2-(ACETYLAMINO)-2-DEOXY-A- HETSYN 4 NDG D-GLUCOPYRANOSE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE HETSYN FUL BETA-L-FUCOSE; 6-DEOXY-BETA-L-GALACTOPYRANOSE; L- HETSYN 2 FUL FUCOSE; FUCOSE; 6-DEOXY-BETA-L-GALACTOSE FORMUL 4 NAG 5(C8 H15 N O6) FORMUL 4 BMA 3(C6 H12 O6) FORMUL 4 MAN 3(C6 H12 O6) FORMUL 4 NDG 2(C8 H15 N O6) FORMUL 4 GAL C6 H12 O6 FORMUL 4 FUL 2(C6 H12 O5) FORMUL 6 HG2 BR2 HG FORMUL 7 HOH *120(H2 O) HELIX 1 1 LYS A 246 MET A 252 1 7 HELIX 2 2 LEU A 309 GLY A 316 1 8 HELIX 3 3 SER A 354 THR A 359 1 6 HELIX 4 4 LYS A 414 GLY A 420 1 7 HELIX 5 5 LYS B 246 MET B 252 1 7 HELIX 6 7 SER B 354 MET B 358 5 5 HELIX 7 8 LYS B 414 GLN B 419 1 6 HELIX 8 9 THR C 62 SER C 66 5 5 HELIX 9 10 LYS C 114 THR C 116 5 3 SHEET 1 A 4 SER A 239 PHE A 243 0 SHEET 2 A 4 GLU A 258 VAL A 266 -1 O VAL A 262 N PHE A 241 SHEET 3 A 4 TYR A 300 THR A 307 -1 O VAL A 302 N VAL A 263 SHEET 4 A 4 LYS A 288 THR A 289 -1 N LYS A 288 O VAL A 305 SHEET 1 B 4 VAL A 282 VAL A 284 0 SHEET 2 B 4 LYS A 274 VAL A 279 -1 N TRP A 277 O VAL A 284 SHEET 3 B 4 CYS A 321 SER A 324 -1 O LYS A 322 N ASN A 276 SHEET 4 B 4 ILE A 332 LYS A 334 -1 O ILE A 332 N VAL A 323 SHEET 1 C 4 GLN A 347 LEU A 351 0 SHEET 2 C 4 GLN A 362 PHE A 372 -1 O THR A 366 N LEU A 351 SHEET 3 C 4 PHE A 404 ASP A 413 -1 O LEU A 410 N LEU A 365 SHEET 4 C 4 TYR A 391 THR A 393 -1 N LYS A 392 O LYS A 409 SHEET 1 D 4 GLN A 347 LEU A 351 0 SHEET 2 D 4 GLN A 362 PHE A 372 -1 O THR A 366 N LEU A 351 SHEET 3 D 4 PHE A 404 ASP A 413 -1 O LEU A 410 N LEU A 365 SHEET 4 D 4 VAL A 397 LEU A 398 -1 N VAL A 397 O PHE A 405 SHEET 1 E 3 ALA A 378 GLU A 382 0 SHEET 2 E 3 PHE A 423 MET A 428 -1 O SER A 424 N GLU A 382 SHEET 3 E 3 THR A 437 LEU A 441 -1 O LEU A 441 N PHE A 423 SHEET 1 F 4 SER B 239 PHE B 243 0 SHEET 2 F 4 GLU B 258 VAL B 266 -1 O VAL B 264 N SER B 239 SHEET 3 F 4 THR B 299 THR B 307 -1 O VAL B 302 N VAL B 263 SHEET 4 F 4 ALA B 287 LYS B 290 -1 N LYS B 288 O VAL B 305 SHEET 1 G 4 SER B 239 PHE B 243 0 SHEET 2 G 4 GLU B 258 VAL B 266 -1 O VAL B 264 N SER B 239 SHEET 3 G 4 THR B 299 THR B 307 -1 O VAL B 302 N VAL B 263 SHEET 4 G 4 GLU B 293 GLU B 294 -1 N GLU B 294 O THR B 299 SHEET 1 H 4 VAL B 282 VAL B 284 0 SHEET 2 H 4 TRP B 277 VAL B 279 -1 N VAL B 279 O VAL B 282 SHEET 3 H 4 TYR B 319 VAL B 323 -1 O LYS B 320 N TYR B 278 SHEET 4 H 4 ILE B 332 ILE B 336 -1 O ILE B 336 N TYR B 319 SHEET 1 I 4 GLN B 347 LEU B 351 0 SHEET 2 I 4 GLN B 362 PHE B 372 -1 O LYS B 370 N GLN B 347 SHEET 3 I 4 PHE B 404 ASP B 413 -1 O LEU B 410 N LEU B 365 SHEET 4 I 4 TYR B 391 THR B 393 -1 N LYS B 392 O LYS B 409 SHEET 1 J 4 GLN B 347 LEU B 351 0 SHEET 2 J 4 GLN B 362 PHE B 372 -1 O LYS B 370 N GLN B 347 SHEET 3 J 4 PHE B 404 ASP B 413 -1 O LEU B 410 N LEU B 365 SHEET 4 J 4 VAL B 397 LEU B 398 -1 N VAL B 397 O PHE B 405 SHEET 1 K 3 ALA B 378 GLU B 382 0 SHEET 2 K 3 PHE B 423 MET B 428 -1 O MET B 428 N ALA B 378 SHEET 3 K 3 THR B 437 LEU B 441 -1 O THR B 437 N VAL B 427 SHEET 1 L 3 VAL C 9 GLU C 13 0 SHEET 2 L 3 VAL C 25 GLN C 30 -1 O GLN C 30 N VAL C 9 SHEET 3 L 3 SER C 55 ILE C 58 -1 O ILE C 58 N VAL C 25 SHEET 1 M 5 SER C 18 LEU C 20 0 SHEET 2 M 5 GLN C 83 HIS C 87 1 O HIS C 87 N VAL C 19 SHEET 3 M 5 GLY C 67 GLN C 72 -1 N GLY C 67 O LEU C 84 SHEET 4 M 5 GLN C 41 HIS C 44 -1 N PHE C 43 O ARG C 70 SHEET 5 M 5 SER C 47 ILE C 49 -1 O SER C 47 N HIS C 44 SHEET 1 N 3 LEU C 91 GLN C 94 0 SHEET 2 N 3 ILE C 106 SER C 112 -1 O ARG C 109 N GLN C 94 SHEET 3 N 3 ASP C 138 ILE C 141 -1 O ILE C 141 N ILE C 106 SHEET 1 O 4 ASP C 129 HIS C 135 0 SHEET 2 O 4 LEU C 118 GLN C 125 -1 N LYS C 120 O HIS C 134 SHEET 3 O 4 GLY C 150 VAL C 158 -1 O PHE C 153 N LEU C 124 SHEET 4 O 4 LYS C 161 SER C 164 -1 O VAL C 163 N GLY C 156 SHEET 1 P 4 ASP C 129 HIS C 135 0 SHEET 2 P 4 LEU C 118 GLN C 125 -1 N LYS C 120 O HIS C 134 SHEET 3 P 4 GLY C 150 VAL C 158 -1 O PHE C 153 N LEU C 124 SHEET 4 P 4 VAL C 168 ILE C 170 -1 O VAL C 168 N TYR C 152 SSBOND 1 CYS A 261 CYS A 321 1555 1555 2.04 SSBOND 2 CYS A 367 CYS A 425 1555 1555 2.03 SSBOND 3 CYS B 261 CYS B 321 1555 1555 2.03 SSBOND 4 CYS B 367 CYS B 425 1555 1555 2.03 SSBOND 5 CYS C 29 CYS C 71 1555 1555 2.03 SSBOND 6 CYS C 110 CYS C 154 1555 1555 2.03 LINK ND2 ASN A 297 C1 NAG D 1 1555 1555 1.45 LINK ND2 ASN B 297 C1 NAG E 1 1555 1555 1.46 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.39 LINK O6 NAG D 1 C1 FUL D 8 1555 1555 1.41 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.38 LINK O6 BMA D 3 C1 MAN D 4 1555 1555 1.40 LINK O3 BMA D 3 C1 BMA D 7 1555 1555 1.41 LINK O2 MAN D 4 C1 NDG D 5 1555 1555 1.40 LINK O4 NDG D 5 C1 GAL D 6 1555 1555 1.40 LINK O4 NAG E 1 C1 NDG E 2 1555 1555 1.41 LINK O6 NAG E 1 C1 FUL E 8 1555 1555 1.41 LINK O4 NDG E 2 C1 BMA E 3 1555 1555 1.40 LINK O3 BMA E 3 C1 MAN E 4 1555 1555 1.39 LINK O6 BMA E 3 C1 MAN E 6 1555 1555 1.39 LINK O2 MAN E 4 C1 NAG E 5 1555 1555 1.40 LINK O2 MAN E 6 C1 NAG E 7 1555 1555 1.40 LINK SD MET A 252 HG HG2 A 456 1555 1555 2.80 CISPEP 1 TYR A 373 PRO A 374 0 0.62 CISPEP 2 TYR B 373 PRO B 374 0 -1.21 CISPEP 3 GLU C 13 PRO C 14 0 0.50 CRYST1 73.846 102.385 123.069 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013542 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009767 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008126 0.00000